These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20613679)

  • 1. PET tracer for evaluating brain tumors: a clinical need-based rational approach.
    Basu S
    Nucl Med Commun; 2010 Sep; 31(9):763-5. PubMed ID: 20613679
    [No Abstract]   [Full Text] [Related]  

  • 2. PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
    Kläsner BD; Krause BJ; Beer AJ; Drzezga A
    Expert Rev Anticancer Ther; 2010 May; 10(5):609-13. PubMed ID: 20469990
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of amino-tracer PET for decision-making in neuro-oncology.
    Suchorska B; Albert NL; Tonn JC
    Curr Opin Neurol; 2018 Dec; 31(6):720-726. PubMed ID: 30239359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET tracer development--a tale of mice and men.
    Hicks RJ; Dorow D; Roselt P
    Cancer Imaging; 2006 Oct; 6(Spec No A):S102-6. PubMed ID: 17114061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors.
    Rickhey M; Koelbl O; Eilles C; Bogner L
    Strahlenther Onkol; 2008 Oct; 184(10):536-42. PubMed ID: 19016044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT and PET imaging of brain tumors.
    Hustinx R; Alavi A
    Neuroimaging Clin N Am; 1999 Nov; 9(4):751-66. PubMed ID: 10517943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging (PET) of brain tumors.
    Basu S; Alavi A
    Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
    No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How many PET tracers do we need?
    Schwaiger M; Wester HJ
    J Nucl Med; 2011 Dec; 52 Suppl 2():36S-41S. PubMed ID: 22144553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography in evaluating the response to treatment of brain tumors, lymphomas and breast cancer].
    Giannopoulou C; Fragaki C
    Hell J Nucl Med; 2006; 9(2):117-25. PubMed ID: 16894421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.
    Farmakis G; Brandau W; Hellwig D; Wollenweber F; Schaefer A; Kirsch CM; Samnick S
    Clin Nucl Med; 2008 Jun; 33(6):441-2. PubMed ID: 18496461
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
    Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
    Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13N-NH3: a selective contrast-enhancing tracer for brain tumor.
    Xiangsong Z; Xinjian W; Yong Z; Weian C
    Nucl Med Commun; 2008 Dec; 29(12):1052-8. PubMed ID: 18987525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
    Kelly PA; Metcalfe K; Evanson J; Sabin I; Plowman PN; Monson JP
    Horm Res; 2009; 72(3):190-6. PubMed ID: 19729952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Applications of Positron Emission Tomography for Neurosurgery(4)Applications of Positron Emission Tomography for Assessing Brain Tumors].
    Yamaguchi S
    No Shinkei Geka; 2017 Nov; 45(11):1015-1024. PubMed ID: 29172209
    [No Abstract]   [Full Text] [Related]  

  • 17. α-D-Glucose as a non-radioactive MRS tracer for metabolic studies of the brain.
    Weng G; Radojewski P; Slotboom J
    Sci Rep; 2023 Apr; 13(1):6159. PubMed ID: 37061615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET of hypoxia: current and future perspectives.
    Carlin S; Humm JL
    J Nucl Med; 2012 Aug; 53(8):1171-4. PubMed ID: 22789676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of αvβ3 expression in cancer patients.
    Beer AJ; Schwaiger M
    Methods Mol Biol; 2011; 680():183-200. PubMed ID: 21153382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pre-requisite of a second-generation glioma PET biomarker.
    Borbely K; Wintermark M; Martos J; Fedorcsak I; Bognar L; Kasler M
    J Neurol Sci; 2010 Nov; 298(1-2):11-6. PubMed ID: 20739034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.